Literature DB >> 20505012

Phylogenetic evidence for a recent spread of two populations of human enterovirus 71 in European countries.

A Mirand1, I Schuffenecker, C Henquell, G Billaud, G Jugie, D Falcon, A Mahul, C Archimbaud, E Terletskaia-Ladwig, S Diedrich, H P Huemer, M Enders, B Lina, H Peigue-Lafeuille, J-L Bailly.   

Abstract

Human enterovirus 71 (EV-71) is a cause of seasonal epidemics of hand, foot and mouth disease, and of less common but severe neurological manifestations. Uncertainty persists regarding the circulation of virus populations in several geographical areas and the timescale of their dissemination. We determined EV-71 sequences at loci 1D (VP1 capsid protein) and 3CD (non-structural proteins) in 86 strains recovered in Austria, France and Germany and performed an evolutionary genetic study of extant virus populations. Phylogenetic analyses positioned 78 of the 86 sequences within two clades among subgenogroups C1 and C2. A minor sequence cluster was assigned to subgenogroup C4. Analyses incorporating the available sequences estimated the substitution rate in genogroup C at 3.66 x 10(-3) and 4.46 x 10(-3) substitutions per site year(-1) for loci 1D and 3CD, respectively, assuming a relaxed molecular-clock model for sequence evolution. Most of the 'European' strains belonged to clades C1b and C2b, which originated in 1994 [95 % confidence interval (CI), 1992.7-1995.8] and 2002 (95 % CI, 2001.6-2003.8), respectively. Estimates of divergence times for locus 3CD were consistent with those measured for locus 1D. Intertwining between clades representing EV-71 subgenogroups and clades corresponding to other enterovirus types (notably early coxsackievirus A prototype strains) in the 3CD phylogeny is highly indicative of ancestral recombination events. Incongruent phylogenetic patterns estimated for loci 1D and 3CD show that a single tree cannot model the epidemic history of circulating EV-71 populations. The evolutionary timescale of genogroup C estimated for both loci was measured only in decades, indicating recent dissemination.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20505012     DOI: 10.1099/vir.0.021741-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  22 in total

Review 1.  Therapeutic and prevention strategies against human enterovirus 71 infection.

Authors:  Chee Choy Kok
Journal:  World J Virol       Date:  2015-05-12

2.  Phylogeography of Coxsackievirus A16 Reveals Global Transmission Pathways and Recent Emergence and Spread of a Recombinant Genogroup.

Authors:  Chervin Hassel; Audrey Mirand; Agnes Farkas; Sabine Diedrich; Hartwig P Huemer; Hélène Peigue-Lafeuille; Christine Archimbaud; Cécile Henquell; Jean-Luc Bailly
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

3.  High frequency and diversity of species C enteroviruses in Cameroon and neighboring countries.

Authors:  Serge Alain Sadeuh-Mba; Maël Bessaud; Denis Massenet; Marie-Line Joffret; Marie-Claire Endegue; Richard Njouom; Jean-Marc Reynes; Dominique Rousset; Francis Delpeyroux
Journal:  J Clin Microbiol       Date:  2012-12-19       Impact factor: 5.948

4.  High Permissiveness for Genetic Exchanges between Enteroviruses of Species A, including Enterovirus 71, Favors Evolution through Intertypic Recombination in Madagascar.

Authors:  Romain Volle; Richter Razafindratsimandresy; Marie-Line Joffret; Maël Bessaud; Sendraharimanana Rabemanantsoa; Seta Andriamamonjy; Jonhson Raharinantoanina; Bruno Blondel; Jean-Michel Heraud; Jean-Luc Bailly; Francis Delpeyroux
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

5.  Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus a6- and coxsackievirus a10-associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China.

Authors:  Ya-Qing He; Long Chen; Wen-Bo Xu; Hong Yang; Han-Zhong Wang; Wen-Ping Zong; Hui-Xia Xian; Hui-Ling Chen; Xiang-Jie Yao; Zhang-Li Hu; Min Luo; Hai-Long Zhang; Han-Wu Ma; Jin-Quan Cheng; Qian-Jin Feng; De-Jian Zhao
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

6.  Evolution and Spatiotemporal Dynamics of Enterovirus A71 Subgenogroups in Vietnam.

Authors:  Nguyen Thi Thanh Thao; Celeste Donato; Vu Thi Huyen Trang; Nguyen Trung Kien; Ph M Mai Thuy Trang; Tran Quoc Khanh; Dang Thi Nguyet; October M Sessions; Hoang Quoc Cuong; Phan Trong Lan; Vu Thi Que Huong; H Rogier van Doorn; Dhanasekaran Vijaykrishna
Journal:  J Infect Dis       Date:  2017-12-12       Impact factor: 5.226

7.  Surveillance for Enteroviruses Associated with Hand, Foot, and Mouth Disease, and Other Mucocutaneous Symptoms in Spain, 2006-2020.

Authors:  Nieves Martínez-López; Carmen Muñoz-Almagro; Cristian Launes; Ana Navascués; Manuel Imaz-Pérez; Jordi Reina; María Pilar Romero; Cristina Calvo; Montserrat Ruiz-García; Gregoria Megias; Juan Valencia-Ramos; Almudena Otero; María Cabrerizo
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

8.  Epidemiological and etiological characteristics of hand, foot, and mouth disease in Henan, China, 2008-2013.

Authors:  Xueyong Huang; Haiyan Wei; Shuyu Wu; Yanhua Du; Licheng Liu; Jia Su; Yuling Xu; Haifeng Wang; Xingle Li; Yanxia Wang; Guohua Liu; Weijun Chen; John David Klena; Bianli Xu
Journal:  Sci Rep       Date:  2015-03-10       Impact factor: 4.379

9.  Hand, foot, and mouth disease outbreak and coxsackievirus A6, northern Spain, 2011.

Authors:  Milagrosa Montes; Juncal Artieda; Luis D Piñeiro; Marina Gastesi; Inmaculada Diez-Nieves; Gustavo Cilla
Journal:  Emerg Infect Dis       Date:  2013-04       Impact factor: 6.883

10.  Molecular comparison and evolutionary analyses of VP1 nucleotide sequences of new African human enterovirus 71 isolates reveal a wide genetic diversity.

Authors:  Maël Bessaud; Richter Razafindratsimandresy; Antoine Nougairède; Marie-Line Joffret; Jagadish M Deshpande; Audrey Dubot-Pérès; Jean-Michel Héraud; Xavier de Lamballerie; Francis Delpeyroux; Jean-Luc Bailly
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.